Ipriflavone

Ipriflavone has been studied in 1 paper since 2016: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 2016: “The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats”.

Intervention

1 paper studies it1 more mentions it1 findingUpdated

PubChemChEBIMeSH

See all 2 papers on ipriflavone

At a glance

The findings reach mice, none yet in people. 1 lab in 2 countries.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 2 countries
  • Animals1

What did studies of ipriflavone find?

1

Studies of ipriflavone measured one outcome, osteopenia.

Osteopenia

downin rats1

1 study
  1. Ipriflavone prevents osteopenia in rats (applied alone, during development of osteopenia after orchidectomy).

    “during the development of osteopenia, AKG and IP when applied exclusively, counteracts osteopenia development”

    Animalsapplied alone, during development of osteopenia after orchidectomytibia50 mg/kg b.w.60 daysmales

    The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats

    The journal of nutrition, health & aging

More on Osteopenia

Latest